Silverback Asset Management »

Cytokinetics shares owned by Silverback Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Silverback Asset Management from 13F filings

Historical chart of Silverback Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Silverback Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.5M 100k 85.19

More positions owned by Silverback Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Semtech Corp Note 1.625%11/0 (Principal)
MKS Note 1.250% 6/0 (Principal)
Avnet Note 1.750% 9/0 (Principal)
Jazz Investments I Note 3.125% 9/1 (Principal)
Indie Semiconductor Note 3.500% 12/1 (Principal)
Cheesecake Factory Note 2.000% 3/1 (Principal)
Cyberark Software Note 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Cracker Barrel Old Ctry Stor Note 1.750% 9/1 (Principal)
Porch Group Debt 9.000% 5/1 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Dropbox Note 3/0 (Principal)
Nutanix Note 0.250%10/0 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Silverback Asset Management

Top funds holding Cytokinetics

BlackRock
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
venBio Select Advisor
Bank of America Corporation
Susquehanna International
Geode Capital Management
Rtw Investments
Armistice Capital
Polar Capital Holdings
Citadel Advisors
Goldman Sachs Group

View all funds holding Cytokinetics